The gut microbiota–Toll-like receptor 4(TLR4)–nuclear factor kappa B(NF-κB) signaling is a key controller of low-grade chronic inflammation and insulin resistance in type 1 (T1DM) and type 2 diabetes mellitus (T2DM). Here, TLR4 is linked to type 1 diabetes mellitus.